Arjo Unveils New Strategy to Enhance Performance
Medical technology company Arjo presented a new strategy today focused on strengthening its core competencies and customer-centricity. The company targets a significant EBIT improvement by mid-2029.
Medical technology firm Arjo unveiled a new strategy today aimed at enhancing its performance by focusing on its core strengths and building a stronger future platform. The plan was presented during the company's Capital Markets Day.
The strategy involves implementing a more customer-centric operating model and commits to delivering an earnings before interest and taxes (EBIT) improvement of approximately 350 million SEK compared to 2025 levels by the middle of 2029. This financial target relies on leveraging Arjo's existing market positions and core capabilities.
Arjo plans to increase penetration in underrepresented market segments, refine its portfolio priorities, and more effectively utilize its capabilities across different markets and functions. The company anticipates this strategic shift will bolster its standing in the healthcare technology sector over the long term.